Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.

Registration Now Open for Pharmacovigilance Europe Conference 2025: Innovation, Integration and Advancing Global Pharmacovigilance In The Digital Age (London, United Kingdom - May 21-22, 2025) - ...

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The International Directory of ...

Invest in SPDR S&P Biotech ETF (XBI) for long-term growth potential and diverse, equal-weighted portfolio in the biotech ...

Nautilus Biotechnolgy ( ($NAUT) ) has shared an update. On January 27 and 28, 2025, Vijay Pande and Michael Altman informed ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006.

Biotechnology sector supports KOSDAQ delisting reform to exempt revenue criteria Biotech industry backs KOSDAQ reform to ease financial listing requirements without revenue constraints ...